Free Trial
The Market Does Not Wait. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Traws Pharma (TRAW) Institutional Ownership

Traws Pharma logo
$1.65 -0.11 (-6.02%)
As of 01:55 PM Eastern
This is a fair market value price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for Traws Pharma (NASDAQ:TRAW)

Current
Institutional Ownership
Percentage
7.95%
Number of
Institutional Buyers
(last 12 months)
10
Total
Institutional Inflows
(last 12 months)
$2.54M
Number of
Institutional Sellers
(last 12 months)
0
Get TRAW Insider Trade Alerts

Want to know when executives and insiders are buying or selling Traws Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

TRAW Institutional Buying and Selling by Quarter

Traws Pharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/26/2026 Seven Fleet Capital Management LP49,260$56K0.0%N/A0.617%
2/18/2026 XTX Topco Ltd42,210$48K0.0%+294.2%0.528%
2/18/2026 Ikarian Capital LLC678,142$766K0.1%+2,280.0%8.486%
2/18/2026 Squadron Capital Management LLC713,540$806K0.3%N/A8.929%
2/18/2026 Boothbay Fund Management LLC194,536$220K0.0%N/A2.434%
2/17/2026ADAR1 Capital Management LLC154,431$175K0.0%N/A1.933%
2/17/2026 Adage Capital Partners GP L.L.C.730,000$825K0.0%+121.2%9.136%
2/13/2026 State Street Corp25,802$29K0.0%N/A0.323%
2/9/2026 Geode Capital Management LLC61,653$70K0.0%+41.9%0.772%
11/14/2025 Two Sigma Investments LP22,018$41K0.0%+37.1%0.309%
5/16/2025Alyeska Investment Group L.P.52,630$121K0.0%-54.9%0.987%
5/16/2025Adage Capital Partners GP L.L.C.330,000$759K0.0%N/A6.187%
5/15/2025Vestal Point Capital LP175,000$402K0.0%+133.3%3.281%
2/17/2025Vestal Point Capital LP75,000$666K0.0%N/A2.055%
2/17/2025Millennium Management LLC10,012$89K0.0%N/A0.274%
2/17/2025Alyeska Investment Group L.P.116,714$1.04M0.0%N/A3.198%
2/14/2025Boothbay Fund Management LLC28,431$252K0.0%N/A0.779%
2/13/2025Renaissance Technologies LLC10,052$89K0.0%N/A0.275%
2/12/2025Geode Capital Management LLC20,801$185K0.0%N/A0.570%


TRAW Institutional Ownership - Frequently Asked Questions

During the previous two years, 14 institutional investors and hedge funds held shares of Traws Pharma. The most heavily invested institutionals were Adage Capital Partners GP L.L.C. ($825K), Squadron Capital Management LLC ($806K), Ikarian Capital LLC ($766K), Vestal Point Capital LP ($402K), Boothbay Fund Management LLC ($220K), ADAR1 Capital Management LLC ($175K), and Alyeska Investment Group L.P. ($121K).Learn more on Traws Pharma's institutional investors.

7.95% of Traws Pharma's stock is owned by institutional investors. Learn more on TRAW's institutional investor holdings.

Of the 14 institutional investors that purchased Traws Pharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Adage Capital Partners GP L.L.C. ($730K), Squadron Capital Management LLC ($713.54K), Ikarian Capital LLC ($649.65K), Boothbay Fund Management LLC ($222.97K), Vestal Point Capital LP ($175K), ADAR1 Capital Management LLC ($154.43K), and Alyeska Investment Group L.P. ($116.71K).

Institutional investors have bought a total of 2,242,888 shares in the last 24 months. This purchase volume represents approximately $2.54M in transactions.



This page (NASDAQ:TRAW) was last updated on 5/19/2026 by MarketBeat.com Staff.
From Our Partners